NeuroMetrix Inc
NASDAQ:NURO
NeuroMetrix Inc
NASDAQ:NURO
Price:
4.44 USD
0.68%
Market Closed
Updated:
Apr 28, 2024
NeuroMetrix Inc
Cash from Operating Activities
|
NeuroMetrix Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NeuroMetrix Inc
NASDAQ:NURO
|
Cash from Operating Activities
-$6.1m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is NeuroMetrix Inc's Cash from Operating Activities?
Cash from Operating Activities
-6.1m
USD
-6.1m
USD
Based on the financial report for Dec 31, 2023, NeuroMetrix Inc's Cash from Operating Activities amounts to -6.1m USD.
What is NeuroMetrix Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
1%
1%
Over the last year, the Cash from Operating Activities growth was -15%. The average annual Cash from Operating Activities growth rates for NeuroMetrix Inc have been -43% over the past three years , and 1% over the past ten years .
You don't have any saved screeners yet
